FDA says no to half doses; China, UK approve vaccines and more — 5 updates on the COVID-19 vaccine

Here are five updates on the COVID-19 vaccine from the past week:

The FDA sidelined Operation Warp Speed's idea to halve doses of Moderna's COVID-19 vaccine to expedite the vaccine rollout process, saying there is not enough data available to support this measure.

Moderna increased the minimum number of COVID-19 vaccines it expects to produce in 2021 by 20 percent to 600 million, the drugmaker said Jan. 4.

The U.S. likely won't authorize AstraZeneca's COVID-19 vaccine for emergency use until April, Operation Warp Speed Chief Moncef Slaoui, PhD, said in a Politico report.

China granted authorization to Sinopharm's COVID-19 vaccine Dec. 31, approving its first state-developed COVID-19 vaccine for use in the general public.

The United Kingdom became the first country to grant emergency use authorization for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.

More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don't
Stryker's ASC-focused business: 3 things to know

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers